
About AlgaeCytes
AlgaeCytes is a Healthcare company based in United Kingdom founded in 2010. Omega 3 oils and bio-actives are manufactured from freshwater algae. AlgaeCytes has raised $5.73 million across 2 funding rounds from investors including IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK and Germany Trade & Invest. The company has 12 employees. Its chief executive, as recorded, is Naz Bashir. AlgaeCytes offers products and services including Omega-3 EPA and Agricultural Biostimulant. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Food Additives. Its legal entity is ALGAECYTES LIMITED.
Company details
AlgaeCytes was founded in 2010 and is based in Kent, United Kingdom. Operations center on the production of omega 3 oils and bio-actives derived from freshwater algae. These products are supplied to the healthcare, personal care, and nutraceuticals sectors. The focus remains on sustainable sourcing and processing for industrial applications in these markets.
- Headquarters Kent, United Kingdom
- Employees 12
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website algaecytes.com
- Social LinkedIn
- Legal Name Algaecytes Limited
- Date of Incorporation 25 May, 2010
- Jurisdiction CANTERBURY, KENT
- Total Equity Funding$5.73M (USD)
in 2 rounds
- Latest Funding Round$12.6M (USD), Grant
Jan 2022
- Investors
- Employee Count12
Products & Services of AlgaeCytes
AlgaeCytes offers a comprehensive portfolio of products and services, including Omega-3 EPA and Agricultural Biostimulant.
Algae-derived Omega-3 for dietary supplements and health products
Enhances crop growth using sustainable algae-based compounds
Funding Insights of AlgaeCytes
AlgaeCytes has successfully raised a total of $5.73M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $12.6 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.73M
- Total Rounds 2
- Last Round Grant β $12.6M
- First Round $5.73M
(Jan 2022)
- Investors Count 3
All 2 funding rounds of AlgaeCytes with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $5.73M | Series A | β | β | |
| Jan 2022 | $12.6M | Grant | β | β |
3 investors in total: 3 institutional.
Investors in AlgaeCytes
AlgaeCytes has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK and Germany Trade & Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ibg-vc.de | ||||
| bmwi.de | ||||
Germany Trade & Invest is focused on promoting international business expansion in Germany. | gtai.de | Berlin, Germany |
Investor details for AlgaeCytes
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AlgaeCytes
3 people are tracked at AlgaeCytes (2 in leadership, 1 in team); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Naz Bashir | CEO | Leadership |
Andrew Cosentino | CEO | Leadership |
Carolyn Spring | Office Manager | Team |
Complete people profiles for AlgaeCytes
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AlgaeCytes
2 dated milestones of AlgaeCytes across 12 years, from founding to its latest funding, stage changes and deals.
- Founded AlgaeCytes is founded.
- Funding First funding round of $5.7M.
Web traffic of AlgaeCytes
Websites that share an audience with AlgaeCytes (algaecytes.com).
Websites whose visitors overlap most with AlgaeCytes. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
zmsystems.co.uk | zmsystems.co.uk | 100% | #7,739,025 | β | |
| alienergy.org.uk | 82% | 2.2K | #8,434,112 | View details | |
algae-uk.org.uk | algae-uk.org.uk | 80% | β | ||
| deepbridgecapital.com | 75% | #10,831,748 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AlgaeCytes
AlgaeCytes was founded in 2010 and raised its 1st funding round 12 years after it was founded.
AlgaeCytes is headquartered in United Kingdom. It is registered at Kent, United Kingdom.
Naz Bashir is the CEO of AlgaeCytes, as recorded in our data.
AlgaeCytes is a funded company, having raised a total of $5.73M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.73M, raised on Jan 2022.
AlgaeCytes has 12 employees.
AlgaeCytes was founded in 2010 and is based in Kent, United Kingdom. Operations center on the production of omega 3 oils and bio-actives derived from freshwater algae. These products are supplied to the healthcare, personal care, and nutraceuticals sectors. The focus remains on sustainable sourcing and processing for industrial applications in these markets.
AlgaeCytes offers Omega-3 EPA and Agricultural Biostimulant.
AlgaeCytes has 3 investors. Key investors include IBG Beteiligungsgesellschaft Sachsen-Anhalt, BMWK, and Germany Trade & Invest.
AlgaeCytes operates through Algaecytes Limited.